| Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications K Berg, PK Selbo, A Weyergang, A Dietze, L Prasmickaite, A Bonsted, ... Journal of microscopy 218 (2), 133-147, 2005 | 361 | 2005 |
| Photochemical internalization provides time-and space-controlled endolysosomal escape of therapeutic molecules PK Selbo, A Weyergang, A Høgset, OJ Norum, MB Berstad, M Vikdal, ... Journal of Controlled Release 148 (1), 2-12, 2010 | 312 | 2010 |
| Photochemical internalization: a new tool for drug delivery K Berg, M Folini, L Prasmickaite, PK Selbo, A Bonsted, BO Engesaeter, ... Current pharmaceutical biotechnology 8 (6), 362-372, 2007 | 162 | 2007 |
| Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine OJ Norum, PK Selbo, A Weyergang, KE Giercksky, K Berg Journal of Photochemistry and Photobiology B: Biology 96 (2), 83-92, 2009 | 131 | 2009 |
| Targeted delivery and enhanced cytotoxicity of cetuximab− saporin by photochemical internalization in EGFR-positive cancer cells WL Yip, A Weyergang, K Berg, HH Tønnesen, PK Selbo Molecular pharmaceutics 4 (2), 241-251, 2007 | 126 | 2007 |
| Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF–saporin A Weyergang, PK Selbo, K Berg Journal of controlled release 111 (1-2), 165-173, 2006 | 101 | 2006 |
| Photochemical internalization (PCI): a technology for drug delivery K Berg, A Weyergang, L Prasmickaite, A Bonsted, A Høgset, MTR Strand, ... Photodynamic Therapy: Methods and Protocols, 133-145, 2010 | 99 | 2010 |
| Photochemical internalization of tumor‐targeted protein toxins A Weyergang, PK Selbo, MEB Berstad, M Bostad, K Berg Lasers in surgery and medicine 43 (7), 721-733, 2011 | 84 | 2011 |
| Photochemical internalization for intracellular drug delivery. From basic mechanisms to clinical research W Jerjes, TA Theodossiou, H Hirschberg, A Høgset, A Weyergang, ... Journal of clinical medicine 9 (2), 528, 2020 | 83 | 2020 |
| Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells PK Selbo, A Weyergang, A Bonsted, SG Bown, K Berg Journal of Pharmacology and Experimental Therapeutics 319 (2), 604-612, 2006 | 80 | 2006 |
| Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR … PK Selbo, A Weyergang, MS Eng, M Bostad, GM Maelandsmo, A Høgset, ... Journal of controlled release 159 (2), 197-203, 2012 | 69 | 2012 |
| Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance CE Olsen, A Weyergang, VT Edwards, K Berg, A Brech, S Weisheit, ... Biochemical pharmacology 144, 63-77, 2017 | 53 | 2017 |
| Photodynamic Therapy Targets the mTOR Signaling Network in Vitro and in Vivo A Weyergang, K Berg, O Kaalhus, Q Peng, PK Selbo Molecular pharmaceutics 6 (1), 255-264, 2009 | 52 | 2009 |
| Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization M Bostad, M Kausberg, A Weyergang, CE Olsen, K Berg, A Høgset, ... Molecular pharmaceutics 11 (8), 2764-2776, 2014 | 50 | 2014 |
| Photochemical internalization (PCI) of HER2-targeted toxins: Synergy is dependent on the treatment sequence MB Berstad, A Weyergang, K Berg Biochimica et Biophysica Acta (BBA)-General Subjects 1820 (12), 1849-1858, 2012 | 49 | 2012 |
| Photochemical internalization (PCI): A novel technology for activation of endocytosed therapeutic agents K Berg, A Høgset, L Prasmickaite, A Weyergang, A Bonsted, A Dietze, ... Medical Laser Application 21 (4), 239-250, 2006 | 48 | 2006 |
| Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38 … A Weyergang, O Kaalhus, K Berg Molecular cancer therapeutics 7 (6), 1740-1750, 2008 | 45 | 2008 |
| Sustained EKR inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy A Weyergang, PK Selbo, K Berg Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (3), 2659-2670, 2013 | 42 | 2013 |
| Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy MB Berstad, LH Cheung, K Berg, Q Peng, ASV Fremstedal, S Patzke, ... Oncogene 34 (44), 5582-5592, 2015 | 41 | 2015 |
| Photochemical activation of drugs for the treatment of therapy-resistant cancers A Weyergang, MEB Berstad, B Bull-Hansen, CE Olsen, PK Selbo, K Berg Photochemical & Photobiological Sciences 14, 1465-1475, 2015 | 41 | 2015 |
